Polydex Pharmaceuticals Ltd (POLXF)
OTOTC · Common · CUSIP 731728200
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for POLXF and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
731728200
Market Cap
Micro Cap · $5 Million
Business: Polydex Pharmaceuticals Limited, with its subsidiaries based in Toronto, Ontario, and Lenexa, Kansas, is engaged in the research, manufacturing and marketing of biotechnology-based products for veterinary and human pharmaceutical industries worldwide. It is Polydex's mandate to research, develop and market veterinary pharmaceutical products in a hands-on (concept to consumer) fashion. However, the business approach differs with development of its human pharmaceutical pipeline. Here, the mandate is to research and license out potential products to valued partners for development, thereby minimizing R&D expenditures while retaining a royalty revenue stream from successful products.

Company Contact

PRS
George G. Usher
CFO
Sharon L. Wardlaw
Headquarters
421 Comstock Road, Toronto, Ontario, M1L 2H5 Canada
Phone
416-755-2231 · Toll-Free 877-945-1621
Fax
416-755-0334
Investor Relations
George G. Usher · 416-755-2231 · swardlaw@polydex.com
General Email
gu-dextran@rogers.com
Email Form
Material Request Form »
SEC EDGAR Filings
View filings »